230 related articles for article (PubMed ID: 2249048)
1. Rising mortality from cryptogenic fibrosing alveolitis.
Johnston I; Britton J; Kinnear W; Logan R
BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
[TBL] [Abstract][Full Text] [Related]
2. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
[TBL] [Abstract][Full Text] [Related]
3. Occupational distribution and geographic clustering of deaths certified to be cryptogenic fibrosing alveolitis in england and wales.
Harris JM; Cullinan P; McDonald JC
Chest; 2001 Feb; 119(2):428-33. PubMed ID: 11171719
[TBL] [Abstract][Full Text] [Related]
4. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.
Scott J; Johnston I; Britton J
BMJ; 1990 Nov; 301(6759):1015-7. PubMed ID: 2249047
[TBL] [Abstract][Full Text] [Related]
5. Mortality rates from cryptogenic fibrosing alveolitis in seven countries.
Hubbard R; Johnston I; Coultas DB; Britton J
Thorax; 1996 Jul; 51(7):711-6. PubMed ID: 8882078
[TBL] [Abstract][Full Text] [Related]
6. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
Hubbard R; Johnston I; Britton J
Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
Hubbard R; Venn A; Lewis S; Britton J
Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of diagnostic coding of hospital admissions for cryptogenic fibrosing alveolitis.
Johnston ID; Bleasdale C; Hind CR; Woodcock AA
Thorax; 1991 Aug; 46(8):589-91. PubMed ID: 1926030
[TBL] [Abstract][Full Text] [Related]
9. Risk of cryptogenic fibrosing alveolitis in metal workers.
Hubbard R; Cooper M; Antoniak M; Venn A; Khan S; Johnston I; Lewis S; Britton J
Lancet; 2000 Feb; 355(9202):466-7. PubMed ID: 10841131
[TBL] [Abstract][Full Text] [Related]
10. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer?
Harris JM; Cullinan P; McDonald JC
J Epidemiol Community Health; 1998 Sep; 52(9):602-3. PubMed ID: 10320862
[No Abstract] [Full Text] [Related]
11. Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a case-control study.
Hubbard R; Venn A; Britton J
Eur Respir J; 2000 Sep; 16(3):409-13. PubMed ID: 11028652
[TBL] [Abstract][Full Text] [Related]
12. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
[TBL] [Abstract][Full Text] [Related]
13. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
Hubbard R
Eur Respir J Suppl; 2001 Sep; 32():119s-121s. PubMed ID: 11816818
[TBL] [Abstract][Full Text] [Related]
14. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
[TBL] [Abstract][Full Text] [Related]
16. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
[TBL] [Abstract][Full Text] [Related]
17. Adult height and cryptogenic fibrosing alveolitis: a case-control study using the UK general practice research database.
Hubbard R; Venn A
Thorax; 2000 Oct; 55(10):864-6. PubMed ID: 10992540
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of cryptogenic fibrosing alveolitis in Moravia and Silesia.
Kolek V
Acta Univ Palacki Olomuc Fac Med; 1994; 137():49-50. PubMed ID: 7778506
[TBL] [Abstract][Full Text] [Related]
19. Hypothesis: exposure to solvents may cause fibrosing alveolitis.
Billings CG; Howard P
Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888
[TBL] [Abstract][Full Text] [Related]
20. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
